Patrys Ltd has released a press release.
PAT-DX1 significantly improves survival in aggressive GBM
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Patrys
- Europe grants patent for Deoxymab 3E10
- PAT-DX1 Reduces Brain Metastases, Enhances Radiation Therapy
- Appendix 4C - Quarterly - 31 March 2019
- Market Update
- Appendix 4D - Half Year Accounts - 31 December 2018
Later from Patrys
- Appendix 4C - Quarterly - 30 June 2019
- Appendix 4E and 2019 Annual Report
- Appendix 4C - Quarterly - 30 September 2019
- Appendix 4C - Quarterly - 31 December 2019
- Appendix 4D - Half Year Accounts - 31 December 2019
Follow Patrys into a list and get an email when it puts out news.
Follow Patrys